文献速递认知障碍与痴呆

数字钟画测试与正常老年人PET淀粉样蛋白和tau病理的关联

Association of Digital Clock Drawing With PET Amyloid and Tau Pathology in Normal Older Adults.
PubMed 文献 · Neurology · 2021-02-15

本研究纳入300名参与者,评估数字钟画测试(DCTclock)在区分诊断组和检测临床正常老年人(CN)淀粉样蛋白与tau病理生物标志物方面是否优于标准认知评估。结果显示,DCTclock在诊断组间区分优秀(AUC 0.86),且在CN参与者中,其总结评分和空间推理子评分与淀粉样蛋白和tau负荷相关,区分Aβ±组的效果优于PACC(Cohen d=0.76 vs 0.30)。结论认为DCTclock可改善传统认知测试对CN老年人AD病理生物标志物的检测。

要点

  • DCTclock在区分诊断组方面表现出色(AUC 0.86)。
  • 在CN老年人中,DCTclock评分与淀粉样蛋白和tau负荷相关。
  • DCTclock区分Aβ±组的效果优于PACC(d=0.76 vs 0.30)。

核心结论

  • DCTclock可区分诊断组,并在检测CN老年人淀粉样蛋白和tau病理生物标志物方面优于传统认知测试。

研究设计与样本

  • 研究纳入300名参与者,其中264名CN参与者中143名有淀粉样蛋白和tau PET成像(CDR 0,MMSE 28.9±1.2),另36名轻度认知障碍或早期阿尔茨海默痴呆患者(CDR 0.5,MMSE 25.2±3.9)用于评估诊断区分度。

主要发现

  • DCTclock在诊断组间区分优秀(AUC 0.86)。
  • 在CN参与者中,DCTclock总结评分和空间推理子评分与更大的淀粉样蛋白和tau负荷相关。
  • DCTclock区分Aβ±组的效果(Cohen d=0.76)优于PACC(d=0.30)。

临床怎么用

  • DCTclock可作为检测CN老年人早期认知变化和AD病理生物标志物的有效工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether a digital clock-drawing test, DCTclock, improves upon standard cognitive assessments for discriminating diagnostic groups and for detecting biomarker evidence of amyloid and tau pathology in clinically normal older adults (CN). METHODS: Participants from the Harvard Aging Brain Study and the PET laboratory at Massachusetts General Hospital were recruited to undergo the DCTclock, standard neuropsychological assessments including the Preclinical Alzheimer Cognitive Composite (PACC), and amyloid/tau PET imaging. Receiver operating curve analyses were used to assess diagnostic and biomarker discriminability. Logistic regression and partial correlations were used to assess DCTclock performance in relation to PACC and PET biomarkers. RESULTS: A total of 300 participants were studied. Among the 264 CN participants, 143 had amyloid and tau PET imaging (Clinical Dementia Rating [CDR] 0, Mini-Mental State Examination [MMSE] 28.9 ± 1.2). An additional 36 participants with a diagnosis of mild cognitive impairment or early Alzheimer dementia (CDR 0.5, MMSE 25.2 ± 3.9) were added to assess diagnostic discriminability. DCTclock showed excellent discrimination between diagnostic groups (area under the receiver operating characteristic curve 0.86). Among CN participants with biomarkers, the DCTclock summary score and spatial reasoning subscores were associated with greater amyloid and tau burden and showed better discrimination (Cohen d = 0.76) between Aβ± groups than the PACC (d = 0.30). CONCLUSION: DCTclock discriminates between diagnostic groups and improves upon traditional cognitive tests for detecting biomarkers of amyloid and tau pathology in CN older adults. The validation of such digitized measures has the potential of providing an efficient tool for detecting early cognitive changes along the AD trajectory. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that DCTclock results were associated with amyloid and tau burden in CN older adults.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Rentz DM, Papp KV, Mayblyum DV, et al. Association of Digital Clock Drawing With PET Amyloid and Tau Pathology in Normal Older Adults. Neurology. 2021. PMID: 33589537. doi:10.1212/WNL.0000000000011697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。